Advanced Filters
noise

Insulin Clinical Trials

A listing of Insulin medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 523 clinical trials
N Nan Gu

Study on the Improvement of Metabolic Indicators in Type 1 Diabetes Patients

In this study, type 1 diabetes patients from the outpatient department of Peking University First Hospital were selected as the research objects. The investigators plan to recruit 150 participants. Using the course and teaching plan of "Take Control of My Life - Structured Education for Type 1 diabetes" issued by …

18 years of age All Phase N/A
C Camilla Levister

A Study of GNTI-122 in Adults Recently Diagnosed With T1D

This is a 78-week single arm, multi-center, Phase 1 study to evaluate the safety, tolerability, cellular kinetics, and biomarker changes in C-peptide over time of GNTI-122, an investigational cell therapy manufactured from a participant's own blood cells in adult participants with recently diagnosed T1D. After assessment of eligibility, participants who …

18 - 45 years of age All Phase 1
J Jill Weissberg-Benchell, Ph.D.

A Hybrid Effectiveness-implementation Trial to Reduce Diabetes Distress in Teenagers

The investigators will assess both effectiveness (primary) and implementation (secondary) outcomes for a distress-reducing intervention, Supporting Teen Problem Solving (STePS). STePS has already undergone an efficacy trial. The current study allows for evaluating the outcomes of STePS by delivering it in real-world settings, using real-world providers. The investigators will train …

14 - 18 years of age All Phase N/A
S Sémah TAGOUGUI

Effects of Circadian Rhythm on Glycemic Regulation During Continuous Moderate Exercise and Intense Intermittent Disease in Adolescents Living With Type 1 Diabetes

Interventional research with minimal risks and constraints on the effects of circadian rhythm on glycemic regulation during intense moderate, continuous and intermittent exercise in adolescents living with type 1 diabetes

10 - 16 years of age All Phase N/A
S Sue Brown, MD

Safety and Feasibility of a Machine-Learning Bolus Priming Added to Existing Control Algorithm

A randomized crossover trial assessing glycemic control using Reinforcement Learning trained Bolus Priming System (BPS_RL) added to the the Automated Insulin Delivery as Adaptive NETwork (AIDANET algorithm) compared to the original AIDANET algorithm.

18 years of age All Phase N/A
A Alona Hamou, Msc

Carb Counting vs. Simplified Qualitative Meal-Size Estimation

The goal of this study is to compare qualitative meal-size estimation to accurate carb counting in adolescents with Type One Diabetes using all available AID (Automated Insulin Delivery) systems. We will compare glucose control parameters and patient related outcome measures between the groups. 120 children and adolescents with type 1 …

6 - 18 years of age All Phase N/A
L Lutgarda Bozzetto

Glycemic Response to Carbob-Enriched Pasta in Healthy and With Type 1 Diabetes People

Carob (Ceratonia siliqua) is a fruit traditionally used in various Mediterranean countries for the preparation of sweets and beverages. Its pulp, once the seeds are removed, is milled into carob flour, a nutrient-rich food containing fiber, carbohydrates, proteins, and essential minerals such as potassium, magnesium, sodium, phosphorus, and calcium. Carob …

18 - 50 years of age Male Phase N/A
L Laura Nally, MD

Digital Mindfulness for Young Adults With Type 1 Diabetes

The purpose of this research study is to test a mindfulness app called Calm Health among young adults with type 1 diabetes or other absolute insulin deficiency diabetes. Mindfulness is the practice of being aware of your thoughts and feelings in the moment without judgment or negative reaction. All participants …

18 - 30 years of age All Phase N/A
K Kimber Simmons, MD

Precision Administration of Anti-thymocyte Globulin With or Without Verapamil

T cell directed therapy, anti-thymocyte globulin (ATG), in low doses, has been shown to lower HbA1c and preserve endogenous insulin production (measured by C-peptide) in individuals with recently diagnosed type 1 diabetes (T1D). However, not all individuals who received ATG responded to the therapy (i.e., non-responders). Additionally, use of ATG …

6 - 35 years of age All Phase 2
J Jenna Duffecy, PhD

CBTi for the Treatment of Insomnia in Type 1 Diabetes

The goal of this study is to learn if treating insomnia with a therapy intervention in people with type 1 diabetes will help to better control sugar levels, sleep, and quality of life. The questions this study aims to answer include: Will this intervention help the insomnia symptoms? Will obtaining …

18 - 65 years of age All Phase 0

Simplify language using AI